LOW MOLECULAR WEIGHT HEPARINS [PDF]
Medical Journal Armed Forces India, 1998 Low-molecular-weight heparins (LMWH) are a new group of parenteral anticoagulants. They represent a major clinical advance in anticoagulation since the identification of unfractionated heparin (UFH) in 1922 and the introduction of the synthetic coumarin derivative, warfarin, in 1948.
J N, Huang, A, Shimamura
openaire +4 more sources
Low molecular weight heparins [PDF]
Intensive and Critical Care Nursing, 1996 A new class of anticoagulant with advantages over standard heparin were introduced in 1990. Collectively termed low molecular weight heparins, their role is increasing in the treatment and prophylaxis of thromboembolism.
openaire +4 more sources
BMC Musculoskeletal Disorders, 2020 Background Hip fractures have become a severe public health problem, especially in very elderly patients. Most of them are treated with low molecular weight heparin as prophylaxis or treatment of venous thromboembolism.
Yijun Liu +5 more
doaj +1 more source
The Role of Extended Thromboprophylaxis With Low-Molecular-Weight Heparin Following Abdominopelvic Surgery for Cancer. [PDF]
Clin J Oncol NursAdeoye L, Bannerman-Martin A.
europepmc +3 more sources
Present and future of low molecular weight heparin prophylaxis [PDF]
, 1999 Peer ...
Kakkar, V. V.
core +2 more sources
The potential for circular dichroism as an additional facile and sensitive method of monitoring low-molecular-weight heparins and heparinoids [PDF]
, 2009 The ultraviolet circular dichroism (CD) spectra of commercial low-molecular-weight heparins, heparinoids and other anticoagulant preparations have been recorded between 180 and 260 nm.
Fernig, David G. +7 more
core +1 more source
Comparison of Low-Molecular-Weight Heparins Prepared From Ovine Heparins With Enoxaparin
Clinical and Applied Thrombosis/Hemostasis, 2019 Heparin and its low-molecular-weight heparin derivatives are widely used clinical anticoagulants. These drugs are critical for the practice of medicine in applications, including kidney dialysis, cardiopulmonary bypass, and in the management of venous ...
Jianle Chen BS +13 more
doaj +1 more source
Low-Molecular-Weight Heparin–Induced Skin Necrosis Without Thrombocytopenia
Annals of Internal Medicine: Clinical Cases, 2023 Heparin-induced skin necrosis is an immune-based entity that appears secondary to exposure to unfractionated heparin or low-molecular-weight heparin, consisting of the appearance of erythematous lesions that can progress to necrosis at the point of ...
Ana Quiles-Recuenco +4 more
doaj +1 more source
Where and when to inject low molecular weight heparin in hemodiafiltration? : a cross over randomised trial [PDF]
, 2015 Background and Objective : Low molecular weight heparins (LMWHs) are small enough to pass large pore dialysis membranes. Removal of LMWH if injected before the start of the session is possible during high-flux dialysis and hemodiafiltration.
Devreese, Katrien +5 more
core +3 more sources
The anti-cancer properties of heparin and its derivatives: a review and prospect
Cell Adhesion & Migration, 2020 Heparin, including unfractionated heparin (UFH), low-molecular-weight heparin (LMWH) and heparin derivatives, are commonly used in venous thromboembolism treatment and reportedly have beneficial effects on cancer survival.
Sai-Nan Ma +8 more
doaj +1 more source